May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, Amalaki Churna, given at a dose of 3g twice daily, significantly reduced hair fall and improved hair strength in patients with non-cicatricial hair loss over 60 days, without reported adverse effects.
This study reported that Soulflower Rosemary Redensyl Hair Growth Serum (Tetragain™) significantly improved hair growth, increased hair thickness, reduced hair fall, and decreased graying over 120 days, with participants rating the treatment as effective and experiencing no adverse effects.
This study found that DR SKS Hair Growth Booster Serum significantly reduced hair fall and improved hair density in patients with androgenic alopecia over six months, with high patient satisfaction and no major adverse events reported.
October 2020 in “Journal of Ayurvedic and herbal medicine” In this study, Dheedhi Hair Care herbal shampoo significantly reduced hair fall and dandruff compared to a regular shampoo, with no reported side effects.
129 citations
,
October 2007 in “The New England Journal of Medicine” This article discusses the evaluation and management of a 45-year-old woman with diffuse scalp-hair loss and reports no new clinical findings.
90 citations
,
January 2009 in “Journal of cosmetic and laser therapy” In this study, low-level laser therapy showed no statistically significant improvements in hair growth measures, despite some patients experiencing increases in terminal hairs and shaft diameter.
58 citations
,
October 2001 in “Dermatologic Clinics” This review discusses the categorization of hair loss and increased hair density disorders related to systemic diseases and reports no clinical results, emphasizing the potential diagnostic value of history, physical examination, and histopathologic data.
30 citations
,
May 2005 in “Pediatric dermatology” This report reviews familial cases of aplasia cutis of the scalp, noting large irregular defects at the vertex or anterior along the sagittal suture in six families.
23 citations
,
April 2018 in “Journal der Deutschen Dermatologischen Gesellschaft” This review discusses the classification and diagnosis of primary cicatricial alopecias and reports no new clinical results; it highlights the need for effective treatments owing to limited evidence of current therapies' efficacy.
6 citations
,
August 1993 in “Archives of Dermatology” This article describes the first documented case of acquired uncombable hair syndrome in a 39-year-old woman, contributing to the understanding of this rare condition.
4 citations
,
January 2005 in “Elsevier eBooks” This article discusses the key considerations and techniques necessary for successful Follicular Unit Transplantation in hair restoration surgery and reports no new clinical results.
3 citations
,
January 2019 in “Skin Research and Technology” This study found that thermal hair straightening in Asian women was associated with various signs of scalp and hair damage, including CCCA-like hair loss.
3 citations
,
January 2018 in “Dermatology” This study found that transverse sections of scalp biopsies, particularly looking at the anagen:non-anagen hair ratio and presence of pigment casts, effectively distinguish alopecia areata from androgenetic alopecia.
1 citations
,
October 2024 in “BMC Pediatrics” In this study, researchers analyzed data from 132 hospitalized kerion patients over 11 years, mostly children under 11 from rural areas, and noted a significant male predominance and frequent animal contact as potential transmission factors.
1 citations
,
January 2023 in “Journal of Clinical Medicine” This study reported that Tomorrowlabs HIF strengthening factor [HSF] hair restoration technology significantly improved hair thickness, density, shine, and elasticity, while reducing hair loss by an average of 66.8% and enhancing hair growth by up to 32.5% in subjects with androgenic alopecia over nine months.
1 citations
,
June 2012 in “Actas Dermo-Sifiliográficas” This article discusses primary cicatricial alopecia, highlighting the need for early and precise diagnosis to effectively manage and treat these complex inflammatory hair disorders, but presents no new clinical results.
November 2025 in “International Journal of Research in Medical Sciences” In this randomized, placebo-controlled study, Titagen® was found to improve skin, hair, and nail health in adults consuming 5g daily, and reduce pain and improve quality of life for osteoarthritis patients taking 10g daily, without related adverse events.
August 2025 in “Journal of Cosmetic Dermatology” In this study, a DMG-Na and caffeine-containing shampoo significantly reduced hair loss and increased hair density in men with male pattern hair loss over 6 months, compared to a placebo, without adverse effects.
November 2024 in “Journal of Cosmetic Dermatology” This study found that a hair serum with plant-derived ingredients significantly reduced hair loss in women with chronic telogen effluvium over 16 weeks, and was well-tolerated, leading to improved hair characteristics and quality of life compared to a control group.
October 2024 in “International Journal of Research in Dermatology” This study reported that using Mintop Pro+ hair regrowth serum twice daily for 90 days significantly reduced hair fall and increased consumer satisfaction with hair growth and density, without any adverse events, among 161 participants aged 18-55 years with hair loss concerns.
August 2022 in “Our Dermatology Online” This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.
January 2021 in “Medpulse International Journal of General Medicine” This study found that low-level laser therapy significantly increased hair density and thickness in patients with androgenic alopecia over 8 and 16 weeks.
December 2020 in “Actas Dermo-Sifiliográficas” This review reports that low-level laser therapy significantly increased hair density in androgenetic alopecia patients compared to a sham treatment, with variations in effectiveness based on treatment intensity and duration.
This study introduced a customizable ELISA for detecting antibodies against botulinum neurotoxin that matches or surpasses other tests in sensitivity and allows for more efficient and animal-friendly testing when combined with the hemidiaphragm assay.
3 citations
,
April 1982 in “Clinics in Plastic Surgery” This study suggests that integrating scalp reduction into male pattern baldness treatment may reduce time, trouble, and cost by about one third compared to conventional hair restoration methods.
2 citations
,
September 2016 in “Springer eBooks” This article discusses how the brain's neural circuits evaluate skin aging to judge social standing and suggests that people often attempt to deceive themselves and others about their true age.
139 citations
,
June 2003 in “Journal of Investigative Dermatology Symposium Proceedings” This article reviews androgenetic alopecia in women, highlighting diagnosis criteria and noting that topical minoxidil is currently the only proven treatment for hair growth; it reports no clinical trial findings.
90 citations
,
June 2006 in “The American Journal of Dermatopathology” This review outlines the classification, histopathologic presentation, and pathogenetic concepts of scarring and nonscarring alopecias, reporting no new clinical results and emphasizing the need for clinicopathologic correlation.
88 citations
,
April 2011 in “Archives of Dermatology” This study found a high prevalence of central hair loss among African American women and associated it with diabetes mellitus type 2, bacterial scalp infections, and hairstyles causing traction.
81 citations
,
March 2009 in “Seminars in Cutaneous Medicine and Surgery” This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.